Upstream Bio (UPB) Restructuring Costs (2024 - 2026)

Upstream Bio (UPB) posted quarterly Restructuring Costs of $1.1 million for Q1 2026, up 5.6% year-over-year from $1.1 million in Q1 2025, and down 14.97% quarter-over-quarter from $1.3 million in Q4 2025.

Upstream Bio (UPB) Restructuring Costs (2024 - 2026) Analysis & Trends

Upstream Bio's Restructuring Costs history runs 3 years deep, the most recent figure standing at $1.1 million for Q1 2026.

  • In Q1 2026, Restructuring Costs rose 5.6% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $4.6 million (up 77.37% YoY), while the FY2025 annual figure was $4.5 million, up 127.77% from the prior year.
  • Restructuring Costs for Q1 2026 stood at $1.1 million, down from $1.3 million in the prior quarter.
  • The five-year high for Restructuring Costs was $1.3 million in Q4 2025, with the low at $334000.0 in Q2 2024.
  • The 3-year median for Restructuring Costs is $891000.0 (2025), against an average of $843666.7.
  • The sharpest annual moves came in 2025 and 2026: Restructuring Costs jumped 273.95% in 2025, then rose 5.6% in 2026.
  • Upstream Bio's Restructuring Costs stood at $836000.0 in 2024, then soared by 56.58% to $1.3 million in 2025, then declined by 14.97% to $1.1 million in 2026.
  • Business Quant data shows UPB's Restructuring Costs at $1.1 million in Q1 2026, $1.3 million in Q4 2025, and $891000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Upstream Bio 387.23 Mn 387.23 Mn -3.29 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.19 Mn
Mar 31, 2026 1.11 Mn
Dec 31, 2025 1.31 Mn
Sep 30, 2025 891,000.00
Jun 30, 2025 1.25 Mn
Mar 31, 2025 1.05 Mn
Dec 31, 2024 836,000.00
Sep 30, 2024 348,000.00
Jun 30, 2024 334,000.00
Mar 31, 2024 459,000.00